Many head and neck cancer survivors felt that they lacked knowledge on topics including mental health, diet and exercise, smoking, and more.

The incidence of early-onset cancers is not rising overall, but rates of certain cancers are increasing among younger patients, new data suggest.

The FDA has accepted the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary angioedema.

Delgocitinib cream is more effective and has a better safety profile than oral alitretinoin for the treatment of severe chronic hand eczema.

The USPSTF has reaffirmed their 2018 recommendation for early, universal syphilis screening in pregnant patients based on new studies.

Lower neighborhood socioeconomic status is associated with a greater risk for new hidradenitis suppurativa diagnosis.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Most patients who sought care for vulvovaginal disorders did not report that their health care practitioners were supportive.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara (ustekinumab).

Microneedling was associated with greater rates of treatment adherence than medication alone in patients with androgenetic alopecia.

An estimated 18,968,894 American children lived with at least one parent with a substance use disorder in 2023.

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.